We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at ...

An array of pharmaceutical pills with the company's logo on the bottle ... the space is largely controlled by just two major players—Novo Nordisk and Eli Lilly. According to estimates from ...

Novo Nordisk stock (NVO) jumped more than 2% in trading Wednesday after beating Wall Street's profit estimates for the first quarter and despite a slight cut to its sales forecast for the year.

Weight-loss drug maker Novo Nordisk reported an earnings beat, but sales fell short of expectations. Management gave an encouraging outlook for the rest of 2025. Novo Nordisk trades for less than ...

COPENHAGEN/LONDON, May 7 (Reuters) - Obesity drugmaker Novo Nordisk (NOVOb.CO), opens new tab said on Wednesday it would drop gender representation requirements for senior leadership positions in ...

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

With Wegovy in its portfolio, Novo Nordisk is a very good bet to continue being a winner. As it's currently considered something of an underdog, with its stock priced accordingly, it's also trading at ...

LONDON/COPENHAGEN, May 7 (Reuters) - Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President Donald Trump's executive order to reduce the time it takes to ...

Novo Nordisk on Wednesday managed the unusual feat ... "Having to deal with your disease once a week, in a very simple device solution is very convenient for patients," said Jorgensen, according ...

U.S.-listed shares of Novo Nordisk (NVO) are jumping in premarket trading Wednesday even as the Danish pharmaceutical giant lowered its full-year outlook. The maker of blockbuster weight-loss ...

Novo Nordisk on Wednesday managed the unusual feat of seeing its stock price rise after reducing its earnings outlook. But that’s reflective of the tough times the Danish maker of Ozempic and ...